EAAT2 as a Research Target in Bipolar Disorder and Unipolar Depression: A Systematic Review.

Blacker, Caren J; Millischer, Vincent; Webb, Lauren M; Ho, Ada M C; Schalling, Martin; Frye, Mark A; Veldic, Marin

Blacker, Caren J; Millischer, Vincent; Webb, Lauren M; Ho, Ada M C; Schalling, Martin; Frye, Mark A; Veldic, Marin.

Afiliação

Blacker CJ; Department of Psychiatry and Psychology, Mayo Clinic Depression Center, Mayo Clinic, Rochester, Minnesota, USA.
Millischer V; Department of Molecular Medicine and Surgery (MMK), Karolinska Institutet, Stockholm, Sweden.
Webb LM; Neurogenetics Unit, Center for Molecular Medicine, Karolinska University Hospital, Stockholm, Sweden.
Ho AMC; Mayo Medical School, Mayo Clinic, Rochester, Minnesota, USA.
Schalling M; Department of Molecular Pharmacology and Experimental Therapeutics, Mayo Clinic College of Medicine, Rochester, Minnesota, USA.
Frye MA; Department of Molecular Medicine and Surgery (MMK), Karolinska Institutet, Stockholm, Sweden.
Veldic M; Neurogenetics Unit, Center for Molecular Medicine, Karolinska University Hospital, Stockholm, Sweden.

Mol Neuropsychiatry ; 5(Suppl 1): 44-59, 2020 Apr.

Article em En | MEDLINE | ID: mdl-32399469

Palavras-chave

Bipolar disorder; Depression; EAAT2; Glutamate; SCL1A2

Texto completo

Adicionar na Minha BVS

Imprimir

XML

PubMed Links

Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Tipo de estudo: Systematic_reviews Idioma: En Revista: Mol Neuropsychiatry Ano de publicação: 2020 Tipo de documento: Article País de afiliação: Estados Unidos País de publicação: Suíça

Texto completo

Adicionar na Minha BVS

Imprimir

XML

PubMed Links

Buscar no Google